Skip to content

ASBP

Aspire Biopharma Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.41
−4.21%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
1.00x
Price / sales
120.78x
Price / cash flow
-1.64x

Enterprise value

Enterprise value
-$371.6K
EV / sales
-3.81x
EV / EBITDA
-0.11x
EV / EBIT
0.05x
Market cap
$11.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026